Modern antiretroviral treatments delay disease progression and death and create the possibility for HIV+ individuals to live near-normal life-spans. However, the treatments only partial restore immune function, have unknown long-term (>10 year) toxicities, and likely only partially reverse damage done by the virus prior to the initiation of therapy. The critical question that arises is how will clinicians maximize treatment success and minimize treatment and disease-associated long term toxicities? To answer this question, investigators need access to clinical outcome information that is tightly linked to biologic specimens and socio-biologic data to enable translational research. The CFAR Network of Integrated Clinical Systems (CNICS) project is a new resource that can contribute substantially to the contemporary HIV research agenda. Established in 2002 and funded as an R24 research platform in 2006, CNICS is a clinic-based research network that reflects the outcomes of clinical decisions and management options used in the care of HIV infected individuals at 8 CFAR sites: UAB, U Washington, UCSF, UCSD, Case Western Reserve, Fenway Community Clinic (Brown/Harvard), U North Carolina, and Johns Hopkins. The CNICS project supports a database that serves as a central repository of verified and quality-controlled data from the electronic medical records (EMRs) at each site. The clinical data is linked to patient reported outcome obtained at regular intervals, geospatial data, and to biologic specimens stored in repositories and readily available for use in translational research projects. The mission of CNICS is to provide access to the specimen and data repository to any investigator who submits an approved concept proposal. In this fashion, CNICS is a 'peer-reviewed open access'research platform available to investigators worldwide.
The specific aims for this competitive renewal of CNICS are to: 1: Expand the original CNICS research platform;2: Provide direct access to the expanded CNICS research platform to as many investigators as feasible;and 3: Establish a Mentoring Program that targets early and mid-career investigators engaged in multidisciplinary HIV-focused research.
|Fredericksen, R J; Gibbons, L; Brown, S et al. (2018) Medication understanding among patients living with multiple chronic conditions: Implications for patient-reported measures of adherence. Res Social Adm Pharm 14:540-544|
|Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325|
|Menza, Timothy William; Levine, Kenneth; Grasso, Chris et al. (2018) Evaluation of four algorithms to identify incident syphilis among HIV-positive men who have sex with men engaged in primary care. Sex Transm Dis :|
|Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150|
|DiPrete, Bethany L; Pence, Brian W; Grelotti, David J et al. (2018) Measurement of depression treatment among patients receiving HIV primary care: Whither the truth? J Affect Disord 230:50-55|
|Lesko, Catherine R; Jacobson, Lisa P; Althoff, Keri N et al. (2018) Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities. Int J Epidemiol 47:654-668|
|Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372|
|Hong, Jin-Liern; Jonsson Funk, Michele; LoCasale, Robert et al. (2018) Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population. Am J Epidemiol 187:817-827|
|Rudolph, Jacqueline E; Cole, Stephen R; Edwards, Jessie K et al. (2018) At-Risk Alcohol Use Among HIV-Positive Patients and the Completion of Patient-Reported Outcomes. AIDS Behav 22:1313-1322|
|Lee, Jennifer S; Cole, Stephen R; Achenbach, Chad J et al. (2018) Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy. PLoS One 13:e0197665|
Showing the most recent 10 out of 313 publications